Status:
COMPLETED
Hydroxyapetite Nanoparticles, Tricalcium Phosphate Nanoparticles, and PRF for Treatment of Gingival Recession
Lead Sponsor:
October 6 University
Conditions:
Periodontitis
Eligibility:
All Genders
20-45 years
Phase:
NA
Brief Summary
The aim of the present study was to compare between nanocrystalline hydroxyapatite and tricalcium phosphate carried on PRP membrane in treatment of Miller's class 1 gingival recession in human.
Detailed Description
gingival recession (GR) is apical movement of the gingival margin beyond the cement-enamel junction. The use of free gingival grafts, sliding pedicle grafts, subepithelial connective tissue grafts, en...
Eligibility Criteria
Inclusion
- Patients with good systemic health and no contraindication for periodontal surgery.
- Patients who are able to maintain good oral hygiene.
- Gingival thickness for the site selected should be ≥1mm.
- The height of keratinized gingiva (HKG) for the site selected should be ≥1 mm (HKG is the distance between the most apical point of the gingival margin and the mucogingival junction).
Exclusion
- Active infectious diseases (hepatitis, tuberculosis, HIV, etc….).
- Medically compromised patients.
- Patients taking medications known to cause gingival enlargement.
- Pregnant patients and smokers.
- Previous mucogingival surgery at the defect.
- Restorations or caries in the area to be treated and non vital tooth.
- Teeth which are tilted or rotated.
Key Trial Info
Start Date :
September 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 22 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06016894
Start Date
September 1 2000
End Date
April 22 2023
Last Update
August 30 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.